vimarsana.com
Home
Live Updates
FDA approves first human gene editing therapy for sickle cell disease : vimarsana.com
FDA approves first human gene editing therapy for sickle cell disease
The Food and Drug Administration Friday approved a new sickle cell disease treatment using the CRISPR genome editing technology. It's the first approved human gene editing therapy.
Related Keywords
United States ,
Tennessee ,
Americans ,
Peter Marks ,
Rabi Hanna ,
Nicole Verdun ,
Jennelle Stephenson ,
Drug Administration On ,
Drug Administration ,
Black Americans ,
Cleveland Clinic ,
Sickle Cell Disease ,
Gene Editing ,
Fda ,
Red Blood Cells ,
Gene Therapies ,
Rare Diseases ,
Rispr Genome Editing ,
vimarsana.com © 2020. All Rights Reserved.